EUVIMEDEUVIMED entdecken
Open Access

Outcomes Analysis of Transcatheter Closure of Atrial Septal Defects

Zakhia S Saliba iD, Lea Bou Karam, Nelly Sleiman, Linda Daou, Raymond N Haddad iD

Journal of the American Heart Association · 21.10.2025 · 14 (20)

DOI: 10.1161/jaha.125.042349 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 21.10.2025. Verfasst von Zakhia S Saliba und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Cardiology, Hotel Dieu de France University Medical Center Saint Joseph University Beirut Lebanon. Hauptthemen laut MEDLINE: Heart Septal Defects, Atrial, Cardiac Catheterization, Septal Occluder Device. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Atrial septal defect device closure is routine, yet clinical success and long‐term outcomes are often overlooked. We aim to identify predictive factors for failure and describe long‐term outcomes.

Methods

A single‐center retrospective review (2006–2021) of 400 patients undergoing transcatheter atrial septal defect closure was conducted. Primary end point was 6‐month composite clinical success, including technical success (implantation and device retention), closure success (trivial/no residual shunt), absence of 30‐day serious adverse events, and no device removal/reintervention. Secondary end points were technical success, procedure success (technical success with less than moderate residual shunt), closure success (clinically insignificant/absent residual shunt), and safety.

Results

The cohort included 43.2% males, with a median age of 14.5 years [Q1–Q3: 8.3–37] and weight of 47.5 kg [25–68]. At baseline, the median stop‐flow defect diameter was 24 mm [18.9–29]; 22.3% had a diameter ≥30 mm, 4.9% had a diameter‐to‐weight ratio of 1.5–1.8, 17.7% were multi‐fenestrated, 39.3% had margin deficiency, and 10.7% had an atrial septal aneurysm. A single device was used in 98.8% of procedures (75.7% Amplatzer, 23.0% Occlutech). Median difference between device size and balloon‐sizing diameter was 1 mm [0–2]. Implantations were pulmonary vein–assisted in 26.8%, guidewire‐assisted in 2.5%, and balloon‐assisted in 3.8%. Technical success at hospital discharge was 95.8%, and procedural success was 94.8%. Closure success was 98.7% (377/382) at 6 months and 98.9% (193/194) at 96 months. Freedom from SAEs was 95.5% at 30 days. Freedom from device events was 97.4% at 6 months. Six‐month composite clinical success rate was 89.3%. Balloon‐assisted implantation (odds ratio [OR], 4.494, [95% CI 1.471–13.729]), guidewire‐assisted implantation (OR 6.559 [95% CI 1.759–24.454]), and smaller device‐to‐balloon sizing difference (OR 0.8000 [95% CI 0.663–0.967]) were independent predictors of failure.

Conclusions

Transcatheter atrial septal defect closure shows high success, with balloon‐ and guidewire‐assisted implantations and smaller device‐to‐balloon‐sizing differences as predictors of clinical failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart Septal Defects, AtrialCardiac CatheterizationSeptal Occluder DeviceHumansMaleFemaleRetrospective StudiesAdolescentChildTreatment OutcomeAdultYoung AdultTime Factors

Stichwörter der Autor:innen

atrial septal defectcomplicationsdevice closureoutcomesrisk factors

Autor:innen und Institutionen

  • Department of Pediatric Cardiology, Hotel Dieu de France University Medical Center Saint Joseph University Beirut Lebanon.
  • Department of Pediatrics, Hotel Dieu de France University Medical Center Saint Joseph University Beirut Lebanon.
  • Direction de la Recherche et de l'Innovation Médicale (DRIM), Marie Lannelongue Innovation Center (MALIC) Hôpitaux Saint Joseph et Marie Lannelongue Le Plessis-Robinson France.
  • INSERM, UMR_S 999, Hypertension Pulmonaire: Physiopathologie and Innovation Thérapeutique (HPPIT), AP-HP, Hôpital Bicêtre, Hôpital Marie Lannelongue (Groupe Hospitalier Paris Saint Joseph), ERN-LUNG Université Paris-Sac…
  • UFR Médecine Université Paris-Saclay Le Kremlin-Bicêtre France.

ORCID-Profile: Zakhia S Saliba, Raymond N Haddad

Zitieren

APA

Saliba, Z. S., Bou Karam, L., Sleiman, N., Daou, L., & Haddad, R. N. (2025). Outcomes Analysis of Transcatheter Closure of Atrial Septal Defects. Journal of the American Heart Association, 14(20). https://doi.org/10.1161/jaha.125.042349

Vancouver

Saliba ZS, Bou Karam L, Sleiman N, Daou L, Haddad RN. Outcomes Analysis of Transcatheter Closure of Atrial Septal Defects. Journal of the American Heart Association. 2025;14(20). doi:10.1161/jaha.125.042349

BibTeX
@article{Saliba2025,
  author = {Saliba, Zakhia S and Bou Karam, Lea and Sleiman, Nelly and Daou, Linda and Haddad, Raymond N},
  title = {Outcomes Analysis of Transcatheter Closure of Atrial Septal Defects},
  journal = {Journal of the American Heart Association},
  year = {2025},
  volume = {14},
  number = {20},
  doi = {10.1161/jaha.125.042349}
}
Kostenlos starten →